Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
51.4M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
21.4M
-
Shares change
-
-67.1K
-
Total reported value, excl. options
-
$427M
-
Value change
-
+$2.08M
-
Put/Call ratio
-
0.57
-
Number of buys
-
37
-
Number of sells
-
-28
-
Price
-
$19.92
Significant Holders of Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) as of Q3 2021
81 filings reported holding MIRM - Mirum Pharmaceuticals, Inc. - Common Stock as of Q3 2021.
Mirum Pharmaceuticals, Inc. - Common Stock (MIRM) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.4M shares
of 51.4M outstanding shares and own 41.69% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.19M shares), FRAZIER MANAGEMENT LLC (3.57M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.28M shares), Novo Holdings A/S (2.45M shares), Rock Springs Capital Management LP (1.53M shares), AXA S.A. (852K shares), VANGUARD GROUP INC (735K shares), BAKER BROS. ADVISORS LP (647K shares), BlackRock Inc. (611K shares), and BVF INC/IL (436K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.